Literature DB >> 16170086

Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

J S Kalkman1, M L Schillings, S P van der Werf, G W Padberg, M J Zwarts, B G M van Engelen, G Bleijenberg.   

Abstract

OBJECTIVE: To assess the prevalence of severe fatigue and its relation to functional impairment in daily life in patients with relatively common types of neuromuscular disorders.
METHODS: 598 patients with a neuromuscular disease were studied (139 with facioscapulohumeral dystrophy, 322 with adult onset myotonic dystrophy, and 137 with hereditary motor and sensory neuropathy type I). Fatigue severity was assessed with Checklist Individual Strength (CIS-fatigue). Functional impairments in daily life were measured with the short form 36 item health questionnaire (SF-36).
RESULTS: The three different neuromuscular patient groups were of similar age and sex. Severe experienced fatigue was reported by 61-74% of the patients. Severely fatigued patients had more problems with physical functioning, social functioning, mental health, bodily pain, and general health perception. There were some differences between the three disorders in the effects of fatigue.
CONCLUSIONS: Severe fatigue is reported by the majority of patients with relatively common types of neuromuscular disorders. Because experienced fatigue severity is associated with the severity of various functional impairments in daily life, it is a clinically and socially relevant problem in this group of patients.

Entities:  

Mesh:

Year:  2005        PMID: 16170086      PMCID: PMC1739364          DOI: 10.1136/jnnp.2004.050005

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Diagnostic criteria for facioscapulohumeral muscular dystrophy.

Authors:  G W Padberg; P W Lunt; M Koch; M Fardeau
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

2.  The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects.

Authors:  J H Vercoulen; O R Hommes; C M Swanink; P J Jongen; J F Fennis; J M Galama; J W van der Meer; G Bleijenberg
Journal:  Arch Neurol       Date:  1996-07

3.  Apathy and hypersomnia are common features of myotonic dystrophy.

Authors:  J S Rubinsztein; D C Rubinsztein; S Goodburn; A J Holland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

4.  Dimensional assessment of chronic fatigue syndrome.

Authors:  J H Vercoulen; C M Swanink; J F Fennis; J M Galama; J W van der Meer; G Bleijenberg
Journal:  J Psychosom Res       Date:  1994-07       Impact factor: 3.006

5.  The impact of fatigue on patients with multiple sclerosis.

Authors:  J D Fisk; A Pontefract; P G Ritvo; C J Archibald; T J Murray
Journal:  Can J Neurol Sci       Date:  1994-02       Impact factor: 2.104

Review 6.  From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins.

Authors:  A E Harding
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

7.  Fatigue in Parkinson's disease.

Authors:  J Friedman; H Friedman
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

8.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

9.  Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations.

Authors:  A A Gabreëls-Festen; P A Bolhuis; J E Hoogendijk; L J Valentijn; E J Eshuis; F J Gabreëls
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Fatigue in postpolio syndrome.

Authors:  M H Berlly; W W Strauser; K M Hall
Journal:  Arch Phys Med Rehabil       Date:  1991-02       Impact factor: 3.966

View more
  57 in total

1.  Problems of adults with a mitochondrial disease - the patients' perspective: focus on loss.

Authors:  Greet Noorda; Theo van Achterberg; Truus van der Hooft; Jan Smeitink; Lisette Schoonhoven; Baziel van Engelen
Journal:  JIMD Rep       Date:  2012-02-24

2.  Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders.

Authors:  J M Gelauff; E M Kingma; J S Kalkman; R Bezemer; B G M van Engelen; J Stone; M A J Tijssen; J G M Rosmalen
Journal:  J Neurol       Date:  2018-06-02       Impact factor: 4.849

3.  Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Yaroslav Winter; Karsten Schepelmann; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Björn Tackenberg; Veit Mylius; Jens-Peter Reese; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

4.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

5.  Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale.

Authors:  Ulla Werlauff; A Højberg; R Firla-Holme; B F Steffensen; J Vissing
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

6.  Patient-identified disease burden in facioscapulohumeral muscular dystrophy.

Authors:  Nicholas E Johnson; Christine Quinn; Eileen Eastwood; Rabi Tawil; Chad R Heatwole
Journal:  Muscle Nerve       Date:  2012-12       Impact factor: 3.217

Review 7.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

8.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

9.  Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Authors:  Joke S Kalkman; Machiel J Zwarts; Maartje L Schillings; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

10.  Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.

Authors:  E L van der Kooi; J S Kalkman; E Lindeman; J C M Hendriks; B G M van Engelen; G Bleijenberg; G W Padberg
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.